Gannet BioChem News and Resources

Gannet BioChem, a specialty chemical Contract Development and Manufacturing Organization (CDMO), has announced key leadership appointments following its acquisition by Ampersand Capital Partners. Nicholas Shackley has been named Chief Executive Officer (CEO), while Chris Edwards joins as Chief Financial Officer

Ampersand Capital Partners, a private equity firm with a focus on life sciences and healthcare, has completed the acquisition of Nektar Therapeutics’ PEGylation reagent manufacturing business. The newly rebranded entity, Gannet BioChem, will operate from its established facility in Huntsville,